|
|
|
|
||
Re: Art Krieg's Checkmate CMP-101 has an oral presentation tomorrowMain difference with Dvax trial is that CMP trial included also subject who did not respond to previous anti pd1 therapry, ie includes also the the patients who achieved 'stable disease' |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
1085 | Re: Art Krieg's Checkmate CMP-101 has an oral presentation tomorrow | clsm | 1 | 4/19/2018 11:56:14 PM |